The phrase "a potent response from" is correct and usable in written English.
It can be used when discussing a strong or impactful reaction or reply from a person or group in various contexts, such as discussions, debates, or analyses.
Example: "The recent events prompted a potent response from the community, highlighting their concerns and demands for change."
Alternatives: "a strong reaction from" or "a powerful reply from".
These included acute exposure to glucose, a condition that has been shown to elicit a potent response from the ChREBP protein (Herman et al., 2012, Postic et al., 2007, Uyeda and Repa, 2006), but which did not yield higher cytoplasmic mRNA levels.
Pericellular trapping of Collagen IV, apart from preventing its incorporation to destination tissues, induces a potent response in adipocytes.
We have previously established that N. gonorrhoeae elicits a potent IFNα response from plasmacytoid dendritic cells, and used cytokine-specific antibody blocking experiments to demonstrate that IFNα was responsible for the HIV-inhibitory effect of N. gonorrhoeae-infected PBMC supernatants [7].
A major response in mice receiving B7-DC XAb is the induction of a potent CTL response that drives the protection of those mice from a lethal melanoma challenge [18], [19].
As expected, un-reconstituted CD3ε°/° recipient mice were unable to mount a CHS response while reconstitution with CD8+ T cells from control NaCl treated donors induced a potent CHS response (mean ear swelling 237 µm±71).
A potent immune response requires both CD4+ T-cell and effector CD8+ responses.
These proteins trigger a potent inflammatory response in a variety of tissues24.
This elevation in type I and III IFN was, however, likely to originate from the KC, since HBV infection in PHH/KC co-cultures still failed to elicit a potent ISG response (Fig. 6m), suggesting that, even though they remain functional in culture, they do not actively interfere with HBV or its ability to subvert innate immune responses.
IFN-γ is important for the development of a potent antitumour response (Ogawa et al, 1998).
